Recently, it was demonstrated that abnormal miR-615-5p downregulation due to promoter hypermethylation limits its inhibition of IGF2 and other targets in PDAC cells, resulting in increased tumor growth, invasion and migration capabilities [43]. This evidence concerns the gene IGF2 and neoplasm.